UNIVERSITY COALITIONS for GLOBAL HEALTH

ACTION ALERT:

PLEASE CALL THE SENATE AND SEEK SUPPORT FOR $50 BILLION AIDS, TB AND MALARIA IN THE NEW U.S. GLOBAL AIDS BILL!

Why we need at least $50 billion in the next Global AIDS Plan:
• Continuing the current growth trajectory based on yearly increases provided by Congress would lead to approximately $50 billion over this period. Thus, this $50 billion simply continues our current leadership.
• $9 billion to protect and retain authorized funding for U.S. TB and malaria programs.

“Hi, my name is _______ and I’m from _(state &school)_. I’m calling to encourage Senator ___(see list below)____to support a U.S. Global AIDS bill that will reauthorize programs at $50 billion over five years for AIDS, TB and malaria. $50 billion would continue US leadership for AIDS and it will ensure the protection and retention of authorized funding for TB and malaria at $9 billion. Please urge Senator_______ to support a full $50billion for global AIDS, TB and malaria.”
Call these Senators:

Sen. Joseph Biden (DE-Democratic Chair) 202-224-5042
Sen. Barbara Boxer (CA) 202-224-3553
Sen. Benjamin Cardin (MD) 202-224-4524
Sen. Robert Casey (PA) 202-224-6324
Sen. Christopher Dodd (CT) 202-224-2823
Sen. Russell Feingold (WI) 202-224-5323
Sen. John Kerry (MA) 202-224-2742
Sen. Robert Menendez (NJ) 202-224-4744
Sen. Bill Nelson (FL) 202-224-5274
Sen. Barack Obama (IL) 202-224-2854
Sen. James Webb (VA) 202-224-4024

A greatly improved and expanded version of PEPFAR has been introduced in Congress, The Global HIV/AIDS, Tuberculosis and Malaria Reauthorization Act of 2008. This bill will be voted on TOMORROW by the Senate Foreign Relations Committee, and we need your immediate help to pass the best bill possible, which should include reauthorization for $50 billion over the next 5 years.

Why $9 billion for Malaria and TB?
• People who suffer malaria and TB infections are at greater risk of HIV infection. Leaving malaria and TB unchecked only fuels the HIV/AIDS crisis.
• We have proven and affordable interventions to prevent and treat malaria and successful treatments for TB that are cost-efficient uses of U.S. taxpayers dollars.
• Funding would allow these programs to scale up and would support much needed research, including operations research and vaccine development

This entry was posted on Wednesday, March 12th, 2008 at 2:49 pm and is filed under HIV/AIDS. You can follow any responses to this entry through the RSS 2.0 feed. You can post a comment, or trackback from your own site.